1. Home
  2. BATRA vs HCM Comparison

BATRA vs HCM Comparison

Compare BATRA & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlanta Braves Holdings Inc. Series A

BATRA

Atlanta Braves Holdings Inc. Series A

HOLD

Current Price

$47.25

Market Cap

2.7B

Sector

Industrials

ML Signal

HOLD

Logo HUTCHMED (China) Limited

HCM

HUTCHMED (China) Limited

HOLD

Current Price

$13.89

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BATRA
HCM
Founded
1991
2000
Country
United States
Hong Kong
Employees
N/A
1811
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BATRA
HCM
Price
$47.25
$13.89
Analyst Decision
Buy
Sell
Analyst Count
2
1
Target Price
$57.00
$13.75
AVG Volume (30 Days)
48.9K
19.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.40
$28.37
Revenue Next Year
$8.54
$17.50
P/E Ratio
N/A
$5.49
Revenue Growth
N/A
N/A
52 Week Low
$38.67
$11.51
52 Week High
$50.45
$19.50

Technical Indicators

Market Signals
Indicator
BATRA
HCM
Relative Strength Index (RSI) 53.94 43.61
Support Level $45.81 $13.09
Resistance Level $48.05 $15.49
Average True Range (ATR) 1.32 0.45
MACD -0.27 -0.02
Stochastic Oscillator 34.79 41.59

Price Performance

Historical Comparison
BATRA
HCM

About BATRA Atlanta Braves Holdings Inc. Series A

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

Share on Social Networks: